Dongmin (Eugene) Bang
-
Ph.D. Candidate in Bioinformatics at Seoul National University @ Bio & Health Informatics Lab. with Prof. Sun Kim
-
Senior Research Scientist @ **AIGENDRUG** Co., Ltd.
-
PharmD & Licensed pharmacist in Republic of Korea
Research Interests:
- Precision medicine and Multi-modal learning
- AI for drug discovery
- Intelligent Knowledge Integration
With a dual background in pharmacy and computational biology, I focus on integrating pharmacological insight with machine learning to tackle a core challenge in drug discovery and precision medicine: extracting actionable knowledge from complex, high-dimensional, and often sparse biomedical data.
My research centers on developing knowledge-aware computational frameworks—including patient-specific gene regulatory modeling, graph-based learning, and multi-modal molecular representation—to improve therapeutic prediction, compound prioritization, and drug-likeness evaluation. These efforts prioritize model interpretability, translational generalizability, and the principled incorporation of domain knowledge into data-driven systems.

✉️ [email protected]
EDUCATION
2021- Ph.D. in Bioinformatics, Seoul National University, Seoul, Korea
- Advisor: Sun Kim
- Dissertation: Modeling Multi-Scale Biomedical Interactions via Transfer Learning and Knowledge Integration for Precision Medicine
2015- Pharm.D., Chung-Ang University, Seoul, Korea
2012- B.S.E. Student in Architectural Engineering, Hanyang University, Seoul, Korea
2010- Sejong Science Highschool
PUBLICATIONS & PROCEEDINGS
<aside>
🎓 Google scholar page
</aside>
(: Equal contributions)*
- D Bang, I Sung, Y Piao, S Lee, S Kim. “BounDr.E: Predicting Drug-likeness via Biomedical Knowledge Alignment and EM-like One-Class Boundary Optimization.” ICML 2025 (Accepted for poster presentation)
- D Bang*, J Kim*, H Song, S Kim. “ADME-Drug-Likeness: Enriching Molecular Foundation Models via Pharmacokinetics-Guided Multi-Task Learning for Drug-likeness Prediction.” ISMB/ECCB 2025 (Accepted)
- Y Kim*, D Bang*, B Koo, J Yi, C Cho, J Choi, S Kim. “MixingDTA: Improved Drug-Target Affinity Prediction by Extending Mixup with Guilt-By-Association.” ISMB/ECCB 2025 (Accepted)
- D Kong*, Y Ha*, HE Yoo*, D Bang, S Kim. “Survey on AI-Drug Discovery with Knowledge Graphs: Data, Algorithm, and Application.” Journal of Computing Science and Engineering (May, 2025)
- S Ha*, D Bang*, S Kim. “FATE-Tox: Fragment Attention Transformer for E(3)-Equivariant Multi-Organ Toxicity Prediction.” Journal of Cheminformatics (May, 2025)
- I Sung*, SS Lee*, D Bang, J Yi, S Kim, SH Lee. “MDTR: A Knowledge-Guided Interpretable Representation for Quantifying Liver Toxicity at Transcriptomic Level.” Frontiers in Pharmacology (January, 2025)
- J Lee*, D Bang*, S Kim. “Residue-Level Multi-View Deep Learning for ATP Binding Site Prediction and Applications in Kinase Inhibitors.” Journal of Chemical Information and Modeling (JCIM) (January, 2025)
- C Cho*, S Lee*, D Bang, Y Piao, S Kim. “ChemAP: Predicting Drug Approval with Chemical Structures before Clinical Trial Phase by Leveraging Multi-Modal Embedding Space and Knowledge Distillation.” Scientific Reports (October, 2024)
- M Pak, D Bang, I Sung, S Kim, S Lee. “DGDRP: Drug-specific Gene selection for Drug Response Prediction via re-ranking through propagating and learning biological network.” Frontiers in Genetics (September, 2024)
- D Bang*, B Koo*, S Kim. “Transfer Learning of Condition-Specific Perturbation in Gene Interactions Improves Drug Response Prediction.” Bioinformatics (June, 2024) - Transferred from ISMB2024
- DY Lee, DH Lee, D Bang, S Kim. “DiSCO: Diffusion Schrödinger Bridge for Molecular Conformer Optimization.” AAAI2024 (February, 2024)
- J Gu*, D Bang*, J Yi*, S Lee, D Kim, S Kim. “A Model-agnostic Framework to Enhance Knowledge Graph-based Drug Combination Prediction with Drug-Drug Interaction Data and Supervised Contrastive Learning.” Briefings in Bioinformatics (August, 2023)
- D Bang, S Lim, S Lee, S Kim. “Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers.” Nature Communications (June, 2023)
- J Shin*, Y Piao*, D Bang, S Kim, K Jo. “DRPreter: Interpretable Anticancer Drug Response Prediction Using Knowledge-Guided Graph Neural Networks and Transformer.” International Journal of Molecular Sciences (IJMS) (November, 2022)
- D Bang*, J Gu*, J Park, D Jeong, B Koo, J Yi, J Shin, I Jung, S Kim, S Lee. “A Survey on Computational Methods for Investigation on ncRNA-Disease Association through the Mode of Action Perspective.” International Journal of Molecular Sciences (IJMS) (September, 2022)
- S Lim*, S Lee*, Y Piao, MG Choi, D Bang, J Gu, S Kim. “On modeling and utilizing chemical compound information with deep learning technologies: A task-oriented approach.” Computational and Structural Biotechnology Journal (CSBJ) (August, 2022)
Pre-prints & Under Review
Conference Appearances
AWARDS AND HONORS
- Best Paper Award, BIOINFO 2024, Gyeongju, Korea - “Transfer Learning of Condition-Specific Perturbation in Gene Interactions Improves Drug Response Prediction”
- Best Paper Award, BIOINFO 2023, Yeosu, Korea - “Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers”
- Best Paper Award in Artificial Intelligence (First among 391), Korea Computer Congress (KCC) 2022, Jeju, Korea - “Leveraging biological knowledge as guide for random walk on heterogenous network for drug repurposing”
GRANTS AND FELLOWSHIPS
[Advanced Medical Researcher Training Support Program]
- Funding Organization: Seoul National University
- Project Title: Predicting Patient Drug Response with AI Using Transfer Learning and Omics Data
- Duration: 2023.12.01 - 2024.11.30
PATENTS
[KR Patent]
APPARATUS AND METHOD FOR MEASURING DRUG-INDUCED HEPATOTOXICITY (I Sung, SS Lee, S Kim, D Bang, J Yi, SH Lee)
- Patent number: 10-2686914, Application number: 10-2023-0164693
- Filing Date: 23 Nov 2023, Registration date: 16 Jul 2024
[KR Patent]
APPARATUS AND METHOD FOR DRUG REPURPOSING (D Bang, S Kim, SS Lee, SH Lee)
- Patent number: 10-2749753, Application number: 10-2023-0164692
- Filing Date: 23 Nov 2023, Registration date: 3 Dec 2024